Headline News about Sanofi-Aventis S.A. ADR
![](https://investorplace.com/wp-content/uploads/2020/11/cash-cow-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2020/04/stockstobuy1600_12.jpg)
![](https://www.investors.com/wp-content/uploads/2024/02/Stock-Raptfda-shutt.jpg)
![](https://g.foolcdn.com/editorial/images/764648/physician-shaking-patients-hand.jpg)
![](https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp)
![](https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp)
![](/next-assets/images/schema-image-default.png)
Sanofi's Earnings Outlook
January 31, 2024
Via Benzinga
![](https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp)
![](https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1726134715.png)
![](https://investorplace.com/wp-content/uploads/2022/10/droplet-test-tube-biotech-1600-3.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/Eli-Lilly_3.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2024/02/Stock-novonordisk-building-03-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/02/05/screenshot_2024-02-05_at_8.18.47_pm.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/Regenreon.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg)
Sanofi (SNY) Q4 2023 Earnings Call Transcript
February 01, 2024
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![](https://cdn.benzinga.com/files/images/story/2024/Sanofi_1.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2020/12/Stock-sanofi-syringe-01-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/02/01/c.h._robinson_worldwide_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/StockMarket-Up-Shutterstock.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/02/01/image21.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/Microsoft-and-Apple.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/SNY-REGN.png?width=1200&height=800&fit=crop)
Regeneron/Sanofi's Largest Selling Drug Dupixent Scores FDA Approval For Infants With Esophagus Inflammation
January 26, 2024
Via Benzinga
Exposures
Product Safety
![](https://www.investors.com/wp-content/uploads/2017/03/stock-pharmaceutical-1-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/Sanofi_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/Sanofi.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.